Skip to content

Optimal vigilance;The influence of learning effects, time of day and napping in between test sessions on the Sustained Attention to Response Task

Optimal vigilance;The influence of learning effects, time of day and napping in between test sessions on the Sustained Attention to Response Task - SART App's: aspects possibly perturbing the score

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON35234
Enrollment
80
Registered
2011-11-04
Start date
2012-01-09
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

slaapstoornissen NA

Interventions

None listed

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Healthy adults aged between 18 and 55, subdivided into four categories matched on age, gender and level of education.

Exclusion criteria

Exclusion criteria: - Complaints of excessive daytime sleepiness. - Conditions significantly influencing attention and/or sleep. - An Epworth Sleepiness Scale Score > 10. - Use of psychotropic medication. - Being unable to completely understand the informed consent and/or the test instructions. - Abnormal sleep-wake pattern: frequently a very short nightsleep duration ( 2 hours of variation in bed times on 3 or more days a week); shift-schedule workers; travelling trough multiple time zones in the past two weeks.

Design outcomes

Secondary

MeasureTime frame
Errors of commission and omission Subdividing total error score into errors of commission and errors of omission is important, as these error types could reflect different cognitive processes. Reaction time data (mean reaction time, coefficient of variation) Measuring reaction time data is important because of the so-called speed-accuracy trade-off.

Primary

MeasureTime frame
SART error score.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)